- NEUTRAL
Quarterly Revenue Paras Healthcare Sep-2026 Quarterly Revenue is Rs 427 Cr which is growth of 0% YoY.
- NEUTRAL
Quarterly Net Profit Paras Healthcare Sep-2026 Quarterly Net Profit is Rs 39 Cr which is growth of 0% YoY.
NSE: PARASHLTH | BSE: 545005|ASM
Paras Healthcare Live Share Price Today, Share Analysis and Chart
aboutParas Healthcare was incorporated on December 21, 1987. It is the fifth largest healthcare provider in terms of bed capacity in North India, Bihar, and Jharkhand. The company has eight hospitals that operate under the “Paras Health” brand, which are ... Read More
834.955.15(0.62%)
323.7K
NSE+BSE Volume
NSE 19 Nov, 2026 3:31 PM
Check Before You Buy
High rank
5Positive4Negative
Pass in checklist55.6%
Check P/E Buy Sell Zone
Not enough data available
Paras Healthcare Stock Price Ranges
Day Price Range0.6% 1 Day return | 835 (LTP) 811.2847.6 LowHigh |
|---|---|
Week Price Range-5.4% 1 Week return | 835 (LTP) 811.2949 LowHigh |
Month Price Range20.5% 1 Month return | 835 (LTP) 706949 LowHigh |
52 Week Price Range20.5% 1 Year return | 835 (LTP) 706949 LowHigh |
Peers
Quarterly
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Paras Healthcare quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Sep '26 | Jun '26 |
|---|---|---|---|
| 427.4 | 402.7 | ||
Operating Exp. | 316.7 | 299.6 | |
Operating Profit | 96.3 | 87 | |
Operating Profit Margin % | 23.32% | 22.50% | |
Depr. | 29.3 | 28.3 | |
Interest | 28.8 | 25.5 | |
Profit Before Tax | 52.7 | 49.3 | |
Tax | 13.5 | 12.6 | |
Net Profit | 39.2 | 36.7 | |
EPS Adj. latest | 3.6 | 3.4 | |
Net profit TTM | - | - | |
Basic EPS TTM | - | - | |
Earnings Transcripts | |||
Results PDF | |||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Paras Healthcare Technical Analysis
Paras Healthcare EMA & SMA
Bullish+1
Bullish2
Bearish1
| 5 Day | 850.0 |
|---|---|
| 10 Day | 834.7 |
| 12 Day | 822.5 |
|---|
Paras Healthcare Delivery And Volume
Daily Avg. Delivery Volume %
19 Nov, 202632.0%
Week24.5%
Month37.3%
Paras Healthcare Active Candlesticks
Spinning Top Uptrend
PositiveNeutralNegative
Paras Healthcare Resistance and Support
831.25
Pivot
| First Resistance | 851.3 |
|---|---|
| Second Resistance | 867.7 |
| Third Resistance | 887.7 |
| First Support | 814.9 |
|---|---|
| Second Support | 794.9 |
| Third Support | 778.5 |
| Day RSI | 59.9 |
|---|---|
| Day MACD | - |
| Day MFI | 78.2 |
| Day MACD Signal Line | - |
Paras Healthcare Beta
| 1 Month | - |
|---|---|
| 1 Year | - |
| 3 Month | - |
|---|---|
| 3 Year | - |
Paras Healthcare Price Change Analysis
↑20.5%
Over 1 Month
LowHigh
706949
↑20.5%
Over 3 Months
LowHigh
706949
↑20.5%
Over 6 Months
LowHigh
706949
↑20.5%
Over 1 Year
LowHigh
706949
Paras Healthcare Corporate Actions
Paras Healthcare Board Meetings
Paras Healthcare past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
105 Nov 2026 | Quarterly Results | - |
Paras Healthcare Research Reports
Paras Healthcare research reports with share price targets, and buy/hold/sell recommendations from top brokers.
# Date | Broker Name | Target | Price When Recommended | Type | Upside | Change Since Recommendation | Links |
|---|---|---|---|---|---|---|---|
| 120 Oct 2026 | Deven Choksey | - | - | IPO Subscribe | - | -% | |
| 218 Oct 2026 | ICICI Direct | - | - | IPO Note | - | -% | |
| 318 Oct 2026 | Ventura | - | - | IPO Subscribe | - | -% |
Paras Healthcare Corporate Filings
Paras Healthcare BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 13 Nov 2026 | Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Transcript of the Earnings Conference Call held to discuss the Financial Results of the Company for the Quarter and half year ended September 30, 2026 | |
| 12 Nov 2026 | Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Schedule of Investor Meet under Regulation 30 of SEBI Listing Regulations | |
| 06 Nov 2026 | Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | Audio Recording of Earnings Call on Financial Results of the Company for the Quarter and Half Year ended September 30, 2026 | |
| 06 Nov 2026 | Paras Healthcare Results Earnings Call for Q2FY27 | Conference Call with Paras Healthcare Management and Analysts on Q2FY27 Performance and Outlook. Listen to the full earnings transcript. | |
| 06 Nov 2026 | Q2FY27 Quarterly Result Announced for Paras Healthcare Ltd. | Healthcare Facilities company Paras Healthcare announced Q2FY27 results Standalone Financial Highlights: Revenue from operations: Standalone revenue from operations for Q2FY27 stood at Rs 4,129.71 million, representing a sequential increase of 6.82% QoQ from Rs 3,866.17 million in Q1FY27 and an expansion of 15.63% YoY from Rs 3,571.34 million in Q2FY26. For H1FY27, standalone revenue reached Rs 7,995.88 million, up 17.50% YoY from Rs 6,804.96 million in H1FY26. Total income: Standalone total income for Q2FY27 was Rs 4,274.23 million, up 6.15% QoQ compared to Rs 4,026.52 million in Q1FY27 and up 15.63% YoY against Rs 3,696.36 million in Q2FY26. For H1FY27, standalone total income totalled Rs 8,300.75 million, marking a 17.83% YoY increase over Rs 7,044.86 million in H1FY26. Profit before tax (PBT): Standalone PBT for Q2FY27 came in at Rs 527.19 million, rising 6.96% QoQ from Rs 492.90 million in Q1FY27 and increasing 67.59% YoY over Rs 314.58 million in Q2FY26. For H1FY27, standalone PBT stood at Rs 1,020.09 million, expanding 80.59% YoY from Rs 564.88 million in H1FY26. Profit after tax (PAT): Standalone PAT for Q2FY27 stood at Rs 391.76 million, gaining 6.63% QoQ relative to Rs 367.41 million in Q1FY27 and climbing 65.15% YoY against Rs 237.22 million in Q2FY26. For H1FY27, standalone PAT grew to Rs 759.17 million, showing a 79.95% YoY growth relative to Rs 421.87 million in H1FY26. Earnings per equity share (EPS): Standalone basic EPS for Q2FY27 arrived at Rs 3.88 per share, climbing 6.59% QoQ from Rs 3.64 in Q1FY27 and up 65.11% YoY from Rs 2.35 in Q2FY26. For H1FY27, standalone basic EPS stood at Rs 7.52, shifting upwards by 80.00% YoY over Rs 4.18 in H1FY26. Consolidated Financial Highlights: Revenue from operations: Consolidated revenue from operations for Q2FY27 was Rs 5,108.95 million, climbing 8.64% QoQ from Rs 4,702.78 million in Q1FY27 and expanding 22.77% YoY over Rs 4,161.25 million in Q2FY26. For H1FY27, consolidated revenue from operations aggregated to Rs 9,811.73 million, a 25.07% YoY expansion from Rs 7,845.12 million in H1FY26. Total income: Consolidated total income stood at Rs 5,173.47 million for Q2FY27, reflecting a sequential growth of 8.06% QoQ from Rs 4,787.46 million in Q1FY27 and a 22.23% YoY growth compared to Rs 4,232.38 million in Q2FY26. For H1FY27, consolidated total income touched Rs 9,960.93 million, up 24.91% YoY compared to Rs 7,974.70 million in H1FY26. Profit before tax (PBT): For Q2FY27, consolidated PBT grew to Rs 542.19 million, moving up 12.67% QoQ from Rs 481.20 million in Q1FY27 and increasing by 173.52% YoY relative to Rs 198.23 million in Q2FY26. For H1FY27, consolidated PBT reached Rs 1,023.39 million, a 298.73% YoY rise relative to Rs 256.66 million in H1FY26. Profit after tax (PAT): Consolidated PAT for Q2FY27 came in at Rs 403.50 million, dipping 18.78% QoQ against Rs 496.82 million in Q1FY27 but increasing by 225.69% YoY over Rs 123.89 million in Q2FY26. For H1FY27, consolidated PAT reached Rs 900.32 million, showing a 692.19% YoY advance over Rs 113.65 million in H1FY26. Earnings per equity share (EPS): Consolidated basic EPS for Q2FY27 stood at Rs 4.00, down 18.70% QoQ against Rs 4.92 in Q1FY27, but growing by 225.20% YoY relative to Rs 1.23 in Q2FY26. For H1FY27, consolidated basic EPS stood at Rs 8.92, increasing by 689.38% YoY compared to Rs 1.13 in H1FY26. Dharminder Kumar Nagar, Managing Director, Paras Healthcare, said: "This quarter marks an important milestone for Paras Health as we report our first results as a listed company. We are pleased to deliver a robust performance, with the quarter's revenue growing 22.8% YoY to Rs. 510.9 crore and PAT rising 3.6 times. Revenue for H1 FY27 at Rs 981 cr grew 25% YoY. Our newer hospitals at Srinagar and Kanpur have ramped up rapidly and turned strongly EBITDA positive, while our mature hospitals continue to deliver industry-leading margins. Out of the IPO proceeds of Rs 500 crore, we deployed Rs 375 crore towards part repayment of our borrowings, making our balance sheet significantly stronger. We will continue to deepen our specialty programmes, including oncology, cardiac, neuro and renal sciences, invest in advanced clinical technology and expand our presence in the underserved markets of North India." Result PDF |
Paras Healthcare Documents
Paras Healthcare Earnings Call
Paras Healthcare earnings calls, including management commentary and AI-generated summaries.
| Date | Title | Links |
|---|---|---|
| 13 Nov 2026 | Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | |
| 06 Nov 2026 | Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | |
| 06 Nov 2026 | Paras Healthcare Results Earnings Call for Q2FY27 | AudioVideo |
Paras Healthcare Investor Presentations
Paras Healthcare investor presentations, including business updates, financial insights, and strategic initiatives.
| Date | Report Title | Links |
|---|---|---|
| 06 Nov 2026 | Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Investor Presentation |
Paras Healthcare - Company Profile
Website: www.parashospitals.com
About the company - Business Profile
Paras Healthcare was incorporated on December 21, 1987. It is the fifth largest healthcare provider in terms of bed capacity in North India, Bihar, and Jharkhand. The company has eight hospitals that operate under the “Paras Health” brand, which are spread across five states and one union territory in North India.
